Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (K23DK109200)
Received: 17 March 2019
Accepted: 14 January 2020
First Online: 20 January 2020
Ethics approval and consent to participate
: The study protocol (which included both the initial trial and the qualitative follow-up study reported in this manuscript) was approved by the Human Research Committee at Partners HealthCare. Informed written consent was obtained from all participants for trial participation, and verbal consent for participation in the qualitative telephone interview was obtained separately. The ethics committee approved the use of verbal consent for the qualitative follow-up study. Verbal consent was obtained for publication of quotes under the condition that the quotes used would not compromise anonymity.
: Not applicable.
: Jean Terranova is an employee of Community Servings. Deborah Wexler reports serving on a Data Monitoring Committee for Novo Nordisk. Linda Delahanty serves on advisory boards for Omada Health, JanaCare, and WW International. All other authors declare they have nothing to disclose.